National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
IBUPROFEN TABLETS , USP
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC00009-0742-19 | 93703 | A | 5 | 9 | 4 | 54 | ||
| MOTRIN | 93703 | A | 5 | 1 | 4 | KX | ||
| MOTRIN TABLETS | 93703 | A | 5 | 1 | 4 | KX | ||
| 0039786 | 4V824 | H | 5 | 9 | 4 | 54 | ||
| NDC55289-0142-30 | 0PTU3 | A | 3 | 2 | 4 | ZZ | ||
| NDC54569-4319-04 | 1YAR0 | A | 3 | 2 | 4 | ZZ | ||
| NDC54569-4319-04 | 1DFY8 | A | 3 | 2 | 4 | ZZ | ||
| NDC00536-3978-07 | 4V824 | H | 5 | 9 | 4 | 54 |
CAGE Information
| Code | Company |
|---|---|
| 0PTU3 | PD-RX PHARMACEUTICALS INC DBA TRIMAR |
| 93703 | PHARMACIA & UPJOHN COMPANY |
| 4V824 | RUGBY GROUP INC |
| 1YAR0 | ALLSCRIPTS HEALTHCARE SOLUTIONS INC |
| 1DFY8 | MERCK SHARP & DOHME CORP. DIV CORPOR |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| SUWT | UNIT OF ISSUE WEIGHT | 0.14 POUNDS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 600.000 MILLIGRAMS IBUPROFEN ACTIVE INGREDIENT |
| EXQT | EXTERIOR CONTAINER QUANTITY | 48 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| ECWT | EXTERIOR CONTAINER WEIGHT | 6.75 POUNDS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | IBUPROFEN TABLETS USP 600MG 30S BT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 30.000 TABLETS |
| CBBL | FEATURES PROVIDED | CHILD RESISTANT CLOSURE |